What is BIOLASE MG?
BIOLASE MG operates at the intersection of medical device manufacturing and dental innovation. By developing advanced laser systems, the company provides dental professionals with the tools necessary to perform complex restorative, surgical, endodontic, and periodontal treatments with heightened precision. The firm's market position is defined by its commitment to reducing patient discomfort and accelerating recovery times, effectively setting a new standard for modern dental care. Through a combination of innovative hardware, comprehensive training programs, and clinical support, BIOLASE MG continues to expand its global footprint, catering to a growing demand for high-tech, minimally invasive dental solutions.
How much funding has BIOLASE MG raised?
BIOLASE MG has raised a total of $89.5M across 9 funding rounds:
Debt
$8M
Share Placement
$5M
Share Placement
$35M
Share Placement
$10M
Share Placement
$12M
Debt
$6M
Stock Offering
$8.5M
Debt
$3M
Debt
$2M
Debt (2012): $8M with participation from Comerica
Share Placement (2014): $5M led by Oracle Partners L.P
Share Placement (2014): $35M supported by Oracle Partners, L.P., Trellus Partners, Camber Capital Management, LLC, Jack W. Schuler Living Trust, Eagle Growth Partners I and II, and Birchview Capital L.P.
Share Placement (2016): $10M featuring Oracle Partners L.P. and Jack W. Schuler Living Trust
Share Placement (2017): $12M backed by Jack W. Schuler and Oracle Investment Management
Debt (2018): $6M with participation from Bridge Bank
Stock Issuance/Offering (2019): $8.5M, investors not publicly disclosed
Debt (2019): $3M supported by Pacific Mercantile Bank
Debt (2020): $2M featuring PPP
Key Investors in BIOLASE MG
Pacific Mercantile Bank
A commercial banking institution providing specialized financial services, including growth capital and asset-based lending, to support the operational needs of small and medium-sized enterprises.
Bridge Bank
A division of Western Alliance Bank that focuses on providing tailored financial solutions and debt financing to technology-driven companies and emerging growth businesses.
Comerica
A diversified financial services company with a strong emphasis on business banking and wealth management, providing essential capital support for corporate expansion.
What's next for BIOLASE MG?
With the recent injection of $2M, BIOLASE MG is well-positioned to accelerate its research and development pipeline and expand its market reach. The company's strategic roadmap likely involves deepening its penetration into international markets while refining its existing laser platforms to meet the evolving needs of dental practitioners. By leveraging its established intellectual property and strong clinical reputation, BIOLASE MG is poised to capitalize on the shift toward digital dentistry and patient-centric care models. Future growth will likely be driven by continued investment in technological advancements and the scaling of its commercial operations to ensure sustained competitive advantage in the global medical device landscape.
See full BIOLASE MG company page
